ESC 365
Menu
Home
Search
Events
Knowledge Track
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
undefined undefined undefined
Contributor content
Presentations
Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study
Event:
ESC Congress 2017
Topic:
Lipids
Session:
Lipid metabolism
Access
Like
ESC 365 is supported by
Explore sponsored resources
